scholarly journals A randomized Phase 2 study comparing different dosing approaches of induction treatment (first cycle) of regorafenib in metastatic colorectal cancer (mCRC) patients

2017 ◽  
Vol 28 ◽  
pp. v206-v207
Author(s):  
G. Argilés Martinez ◽  
E. Sanz-Garcia ◽  
M. Valladares-Ayerbes ◽  
J.M. Viéitez ◽  
P. Garcia-Alfonso ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Induction Treatment ◽  
Phase 2 ◽  
Phase 2 Study ◽  
Randomized Phase 2

scholarly journals Axitinib and/or bevacizumab with modified FOLFOX-6 as first-line therapy for metastatic colorectal cancer: A randomized phase 2 study

Cancer ◽  
2013 ◽  
Vol 119 (14) ◽  
pp. 2555-2563 ◽  
Author(s):  
Jeffrey R. Infante ◽  
Tony R. Reid ◽  
Allen L. Cohn ◽  
William J. Edenfield ◽  
Terrence P. Cescon ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase 2 ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy ◽  
Phase 2 Study ◽  
Randomized Phase 2

scholarly journals A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients

2019 ◽  
Vol 121 (5) ◽  
pp. 378-383 ◽  
Author(s):  
Elena Elez ◽  
Carles Pericay ◽  
Manuel Valladares-Ayerbes ◽  
Inmaculada Bando ◽  
Maria Jose Safont ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Cancer Patients ◽  
Salvage Therapy ◽  
Phase 2 ◽  
Wild Type ◽  
Exon 2 ◽  
Phase 2 Study ◽  
Colorectal Cancer Patients ◽  
Kras Exon
Sign in / Sign up

Export Citation Format

Share Document